Evaluation of two new filtration systems--Fenwal PS400 and Organon Teknika Curesis--and comparison of results with two centrifugation systems--IBM model 2997 and Haemonetics V50. 1985

C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters

Two new filtration systems (Fenwal CPS 10TM - PS 400 and Organon Teknika Curesis - M82) were evaluated and compared with two centrifugal cell separators (IBM 2997 and Haemonetics V50). 11 patients with auto immune diseases and dermatological diseases underwent 230 consecutive plasma exchanges. For the filtration systems, the average whole blood rate was 50 ml/min and the plasma separation rate was about 21 ml/min for a transmembrane pressure about 70 mmHg. The pre/post percent reduction and sieving coefficient were calculated for some plasma and blood components. A variety of laboratory studies was monitored to assess the efficacy of plasma separators, their biocompatibility and some yields. These results show that the 2 filters appear safe and efficacious but their modules are too simple and do not offer a great security (no transmembrane pressure control or no extracorporeal fluid balance). For a blood banker, IBM 2997 seems more interesting if we take in account its characteristics during plasma exchanges and the possibility which is offered to carry out cytapheresis procedures. But for a thrombopenic patient the filtration systems keep their advantages.

UI MeSH Term Description Entries
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005374 Filtration A process of separating particulate matter from a fluid, such as air or a liquid, by passing the fluid carrier through a medium that will not pass the particulates. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Filtrations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D012871 Skin Diseases Diseases involving the DERMIS or EPIDERMIS. Dermatoses,Skin and Subcutaneous Tissue Disorders,Dermatosis,Skin Disease

Related Publications

C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
April 1989, Casopis lekaru ceskych,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
January 1984, Journal of clinical apheresis,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
January 1981, Vox sanguinis,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
January 1991, Transfusion science,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
January 1986, Beitrage zu Infusionstherapie und klinische Ernahrung,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
October 1992, Infusionstherapie und Transfusionsmedizin,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
May 1994, Journal of clinical microbiology,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
June 1992, Applied and environmental microbiology,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
October 2000, Diagnostic microbiology and infectious disease,
C Coffe, and Y Couteret, and J P Pujol, and Y Kieffer, and R Lenys, and J Panouse, and A Peters
January 1986, Journal of clinical apheresis,
Copied contents to your clipboard!